These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11854194)

  • 1. Cross-protective immunity of mice induced by oral immunization with pneumococcal surface adhesin a encapsulated in microspheres.
    Seo JY; Seong SY; Ahn BY; Kwon IC; Chung H; Jeong SY
    Infect Immun; 2002 Mar; 70(3):1143-9. PubMed ID: 11854194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and characterization of Streptococcus pneumoniae palmitoylated pneumococcal surface adhesin A expressed in Escherichia coli.
    De BK; Sampson JS; Ades EW; Huebner RC; Jue DL; Johnson SE; Espina M; Stinson AR; Briles DE; Carlone GM
    Vaccine; 2000 Mar; 18(17):1811-21. PubMed ID: 10699329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baculovirus expression, purification and evaluation of recombinant pneumococcal surface adhesin A of Streptococcus pneumoniae.
    De BK; Sampson JS; Ades EW; Johnson SE; Stinson AR; Crook J; Tharpe JA; Huebner RC; Carlone GM
    Pathobiology; 1999; 67(3):115-22. PubMed ID: 10394131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.
    Gor DO; Ding X; Briles DE; Jacobs MR; Greenspan NS
    Infect Immun; 2005 Mar; 73(3):1304-12. PubMed ID: 15731027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and immunogenicity of capsular polysaccharide-surface adhesin A (PsaA) conjugate of Streptococcuspneumoniae.
    Lin H; Lin Z; Meng C; Huang J; Guo Y
    Immunobiology; 2010 Jul; 215(7):545-50. PubMed ID: 19880214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced immunogenicity of pneumococcal surface adhesin A by genetic fusion to cytokines and evaluation of protective immunity in mice.
    Gor DO; Ding X; Li Q; Schreiber JR; Dubinsky M; Greenspan NS
    Infect Immun; 2002 Oct; 70(10):5589-95. PubMed ID: 12228286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal vaccination with a multicomponent adenovirus-vectored vaccine protects against Streptococcus pneumoniae infection in the lung.
    Arévalo MT; Xu Q; Paton JC; Hollingshead SK; Pichichero ME; Briles DE; Girgis N; Zeng M
    FEMS Immunol Med Microbiol; 2009 Apr; 55(3):346-51. PubMed ID: 19291171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance of young mice to pneumococcal infection can be improved by oral vaccination with recombinant Lactococcus lactis.
    Villena J; Medina M; Racedo S; Alvarez S
    J Microbiol Immunol Infect; 2010 Feb; 43(1):1-10. PubMed ID: 20434117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection elicited by nasal immunization with pneumococcal surface protein A (PspA) adjuvanted with bacterium-like particles against Streptococcus pneumoniae infection in mice.
    Li B; Chen X; Yu J; Zhang Y; Mo Z; Gu T; Kong W; Wu Y
    Microb Pathog; 2018 Oct; 123():115-119. PubMed ID: 29959043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PsaA (pneumococcal surface adhesin A) and PspA (pneumococcal surface protein A) DNA vaccines induce humoral and cellular immune responses against Streptococcus pneumoniae.
    Miyaji EN; Dias WO; Gamberini M; Gebara VC; Schenkman RP; Wild J; Riedl P; Reimann J; Schirmbeck R; Leite LC
    Vaccine; 2001 Dec; 20(5-6):805-12. PubMed ID: 11738744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against fatal pneumonia through mucosal and subcutaneous immunization with the pneumococcal SP0148 protein.
    Huang J; Luo S; Huang M; Zhang T; Min Z; Liu C; Zhang Q; Yang J; Min X
    Microb Pathog; 2019 Apr; 129():206-212. PubMed ID: 30772476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunoprotective effect of combined pneumococcal endopeptidase O and pneumococcal surface adhesin A vaccines against Streptococcus pneumoniae infection].
    Zhang J; Cui YL; Jiang YM
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 May; 19(5):583-589. PubMed ID: 28506354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of four adjuvants revealed the strongest protection against lethal pneumococcal challenge following immunization with PsaA-PspA fusion protein and AS02 as adjuvant.
    Chen X; Li B; Yu J; Zhang Y; Mo Z; Gu T; Kong W; Zhang Y; Wu Y
    Med Microbiol Immunol; 2019 Apr; 208(2):215-226. PubMed ID: 30707297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity differences of a 15-valent pneumococcal polysaccharide conjugate vaccine (PCV15) based on vaccine dose, route of immunization and mouse strain.
    Caro-Aguilar I; Indrawati L; Kaufhold RM; Gaunt C; Zhang Y; Nawrocki DK; Giovarelli C; Winters MA; Smith WJ; Heinrichs J; Skinner JM
    Vaccine; 2017 Feb; 35(6):865-872. PubMed ID: 28087148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
    Lu J; Sun T; Wang D; Dong Y; Xu M; Hou H; Kong FT; Liang C; Gu T; Chen P; Sun S; Lv X; Jiang C; Kong W; Wu Y
    Immunol Invest; 2015; 44(5):482-96. PubMed ID: 26107747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal Immunization with the Commensal
    Shekhar S; Khan R; Schenck K; Petersen FC
    Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30683742
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhanced safety and immunogenicity of a pneumococcal surface antigen A mutant whole-cell inactivated pneumococcal vaccine.
    David SC; Laan Z; Minhas V; Chen AY; Davies J; Hirst TR; McColl SR; Alsharifi M; Paton JC
    Immunol Cell Biol; 2019 Sep; 97(8):726-739. PubMed ID: 31050022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal and systemic immunization with a novel attenuated pneumococcal vaccine candidate confer serotype independent protection against Streptococcus pneumoniae in mice.
    Wu K; Yao R; Wang H; Pang D; Liu Y; Xu H; Zhang S; Zhang X; Yin Y
    Vaccine; 2014 Jul; 32(33):4179-88. PubMed ID: 24945468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
    Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumococcal serotype 19F conjugate vaccine induces cross-protective immunity to serotype 19A in a murine pneumococcal pneumonia model.
    Jakobsen H; Sigurdsson VD; Sigurdardottir S; Schulz D; Jonsdottir I
    Infect Immun; 2003 May; 71(5):2956-9. PubMed ID: 12704178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.